Phone English: +33 4 57 62 83 79 Français: +33 4 57 62 83 67

This year, the scientific research industry had to adapt itself to keep the research moving forward and to continue to provide drugs for better global health. 

As discussion and exchange of thoughts are a pivotal part of translational research we find it important to stay in touch and secure that this scientific knowledge is shared.

That the reason why TransCure bioServices has decided to provide its first Webinar.

Webinar 2020 Session, hosted by Sebastien Tabruyn, PhD, CSO

Who is Sebastien Tabruyn?


Sebastien Tabruyn, PhD Chief Scientific Officer (CSO). He holds a PhD in Molecular Biology from the University of Liege (Belgium). After 15 years of experience as Project leader in renowned international academic research institutes including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia) and the University of Maastricht (Netherlands), he joined TransCure bioServices in 2013 as Head of Molecular Biology and Oncology. Sebastien Tabruyn published 35 peer-reviewed publications in the field of Oncology, Angiogenesis, Inflammation and Immunity.

Webinar 2020 Series

Cancer Immunotherapy

Full human immune system mouse models for preclinical drug candidates. Do’s/don’ts


Full human immune system mouse models and translational predictability. Do’s/don’ts

Infectious diseases

Full human immune system mouse models for HIV, Dengue, CMV and coronavirus

Want to know more and discuss about your own project?

Contact us by email to connect when it matches with your calendar!

Our latest news

TransCure bioServices Welcomes Cathay Capital to Accelerate Its Ambitious Growth

TransCure bioServices Welcomes Cathay Capital to Accelerate Its Ambitious Growth Archamps, June 29th, 2022 – Cathay Capital announced its investment in TransCure bioServices, alongside the management team and Financière Arbevel. With this transaction, TransCure...

TransCure bioServices is AAALAC Accredited

TransCure bioServices receives full AAALAC Accreditation TransCure bioServices is proud to announce that our facility is now fully accredited by the AAALAC, a compelling achievement rewarding hard-work and dedication to the humane and responsible care and use of...

Science VS Sars-Cov-2: science could win

Science could win We all know that 2021 will go into mostly everyone´s history book as the vaccine year against the COVID-19 pandemic.  It made us realize why science is key to understand viruses, bacteria and the interactions between humans and their environment. We...

New Disease Model: human hepatocytes (hu-liver) Mouse Models

TransCure bioServices launches its human hepatocytes (hu-liver) mouse models! Innovative preclinical model thanks to TransCure bioServices ! Our initial human hepatocyte liver disease model (hu-PIRF) has now been fully validated in house thanks to our collaboration...

Our profession:
in vivo pharmacology services

Please feel free to contact us